Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Human cytomegalovirus long non-coding RNA counteracts nuclear cGAS to facilitate immune evasion

Abstract

Viruses have evolved diverse immune evasion strategies, including the targeting of host pattern recognition receptors. The role of viral non-coding RNAs in modulating pattern recognition receptor activity is unclear. Here we show that human cytomegalovirus (HCMV) produces long non-coding RNA4.9 that counteracts the nuclear cyclic GMP–AMP synthase (cGAS)-mediated immune response to facilitate viral infection in human foreskin fibroblasts. RNA4.9 interacts with host cGAS via its 75-nucleotide RNA region with predicted hairpin loops. Binding of RNA4.9 to cGAS inhibits cGAS enzymatic activity as well as downstream interferon response and facilitates productive viral replication. Sterically blocking the folding of the 75-nucleotide region with antisense oligonucleotides during HCMV infection restores cGAS activity and impairs viral replication. In addition, we found that the specific localization of RNA4.9, which concentrates near HCMV DNA, is correlated with its efficient binding to cGAS and subsequent immune suppression. Our findings identify viral non-coding RNAs as key regulators of cGAS and highlight their potential as therapeutic targets.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: HCMV RNA4.9 represses host innate immunity.
Fig. 2: RNA4.9 targets cGAS to accelerate the productive viral lytic replication.
Fig. 3: RNA4.9 interacts with cGAS through a prominent cGAS-binding domain with RNA hairpin loops.
Fig. 4: The 75-nt region of cGAS-binding hairpin loops within RNA4.9 is important for HCMV immune evasion.
Fig. 5: The 3.0–4.0-kb region directs the local accumulation of RNA4.9 near the HCMV DNA and contributes to cGAS inhibition.
Fig. 6: RNA4.9 localization is correlated with efficient RNA4.9–cGAS interaction.

Similar content being viewed by others

Data availability

The raw sequencing data of mRNA-seq and CLIP-seq were deposited in the National Center for Biotechnology Information Gene Expression Omnibus (NCBI GEO) database: GSE268887 and GSE270524, respectively. The whole-genome sequencing data from progeny viruses of the WT and mutant viruses were deposited in the NCBI Sequence Read Archive (SRA) under the BioProject PRJNA1232851. Reads from mRNA sequencing were aligned to the GRCh38 primary assembly (GENCODE V32). Reads from CLIP-seq were aligned to the GRCh38 primary assembly (GENCODE V45) and human herpesvirus 5 strain Toledo genome (GenBank accession GU937742.2). Reads from the whole-genome sequencing were aligned to the human herpesvirus 5 strain Toledo genome (GenBank accession GU937742.2). Source data are provided with this paper.

Code availability

The codes used for analysis of mRNA-seq, CLIP-seq and viral genome sequencing are available via GitHub at https://github.com/dohlee/viral-lncRNA-cGAS, https://github.com/hyejun18/cgas-clip-hcmv and https://github.com/hyejun18/hcmv-wgs-rna49, respectively.

References

  1. Chathuranga, K., Weerawardhana, A., Dodantenna, N. & Lee, J. S. Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing. Exp. Mol. Med. 53, 1647–1668 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Bowie, A. G. & Unterholzner, L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 8, 911–922 (2008).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Tagawa, T., Serquina, A., Kook, I. & Ziegelbauer, J. Viral non-coding RNAs: stealth strategies in the tug-of-war between humans and herpesviruses. Semin. Cell Dev. Biol. 111, 135–147 (2021).

    Article  PubMed  CAS  Google Scholar 

  4. Li, Z. et al. Viral long non-coding RNA regulates virus life-cycle and pathogenicity. Mol. Biol. Rep. 49, 6693–6700 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Tycowski, K. T. et al. Viral noncoding RNAs: more surprises. Genes Dev. 29, 567–584 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Horos, R. et al. The small non-coding vault RNA1-1 acts as a riboregulator of autophagy. Cell 176, 1054–1067 (2019).

    Article  PubMed  CAS  Google Scholar 

  7. Sommerauer, C. & Kutter, C. Noncoding RNAs and RNA-binding proteins: emerging governors of liver physiology and metabolic diseases. Am. J. Physiol. Cell Physiol. 323, C1003–C1017 (2022).

    Article  PubMed  CAS  Google Scholar 

  8. Zuhair, M. et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev. Med Virol. 29, e2034 (2019).

    Article  PubMed  Google Scholar 

  9. Alford, C. A., Stagno, S., Pass, R. F. & Britt, W. J. Congenital and perinatal cytomegalovirus infections. Rev. Infect. Dis. 12, S745–S753 (1990).

    Article  PubMed  Google Scholar 

  10. Britt, W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 325, 417–470 (2008).

    PubMed  CAS  Google Scholar 

  11. Gatherer, D. et al. High-resolution human cytomegalovirus transcriptome. Proc. Natl Acad. Sci. USA 108, 19755–19760 (2011).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Prichard, M. N. et al. Identification of persistent RNA–DNA hybrid structures within the origin of replication of human cytomegalovirus. J. Virol. 72, 6997–7004 (1998).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Masse, M. J. O., Karlin, S., Schachtel, G. A. & Mocarski, E. S. Human cytomegalovirus origin of DNA-replication (Orilyt) resides within a highly complex repetitive region. Proc. Natl Acad. Sci. USA 89, 5246–5250 (1992).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Borst, E. M. & Messerle, M. Analysis of human cytomegalovirus oriLyt sequence requirements in the context of the viral genome. J. Virol. 79, 3615–3626 (2005).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Tai-Schmiedel, J. et al. Human cytomegalovirus long noncoding RNA4.9 regulates viral DNA replication. PLoS Pathog. 16, e1008390 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lee, S. et al. Functional and molecular dissection of HCMV long non-coding RNAs. Sci. Rep. 12, 19303 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Wu, J. et al. Cyclic GMP–AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826–830 (2013).

    Article  PubMed  CAS  Google Scholar 

  18. Tanaka, Y. & Chen, Z. J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal 5, ra20 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  19. Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).

    Article  PubMed  Google Scholar 

  20. Schoggins, J. W. et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691–695 (2014).

    Article  PubMed  CAS  Google Scholar 

  21. Huang, L. S. et al. mtDNA activates cGAS signaling and suppresses the YAP-mediated endothelial cell proliferation program to promote inflammatory injury. Immunity 52, 475–486.e5 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Gulen, M. F. et al. cGAS–STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374–380 (2023).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Gao, D. et al. Activation of cyclic GMP–AMP synthase by self-DNA causes autoimmune diseases. Proc. Natl Acad. Sci. USA 112, E5699–E5705 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Civril, F. et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature 498, 332–337 (2013).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Chen, S., Rong, M., Lv, Y., Zhu, D. & Xiang, Y. Regulation of cGAS activity by RNA-modulated phase separation. EMBO Rep. 24, e51800 (2023).

    Article  PubMed  CAS  Google Scholar 

  26. Xia, P. et al. A circular RNA protects dormant hematopoietic stem cells from DNA sensor cGAS-mediated exhaustion. Immunity 48, 688–701.e7 (2018).

  27. Yoneyama, M. et al. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17, 1087–1095 (1998).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Li, T., Chen, J. & Cristea, I. M. Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion. Cell Host Microbe 14, 591–599 (2013).

    Article  PubMed  CAS  Google Scholar 

  29. Paijo, J. et al. cGAS senses human cytomegalovirus and induces type I interferon responses in human monocyte-derived cells. PLoS Pathog. 12, e1005546 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  30. Biolatti, M. et al. Human cytomegalovirus tegument protein pp65 (pUL83) dampens type I interferon production by inactivating the DNA sensor cGAS without affecting STING. J. Virol. 92, e01774-17 (2018).

  31. Huang, Z. F. et al. Human cytomegalovirus protein UL31 inhibits DNA sensing of cGAS to mediate immune evasion. Cell Host Microbe 24, 69–80.e4 (2018).

  32. Gariano, G. R. et al. The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLoS Pathog. 8, e1002498 (2012).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Fu, Y. Z. et al. Human cytomegalovirus protein UL42 antagonizes cGAS/MITA-mediated innate antiviral response. PLoS Pathog. 15, e1007691 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Volkman, H. E., Cambier, S., Gray, E. E. & Stetson, D. B. Tight nuclear tethering of cGAS is essential for preventing autoreactivity. eLife 8, e47491 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Kujirai, T. et al. Structural basis for the inhibition of cGAS by nucleosomes. Science 370, 455–458 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Li, T. et al. Phosphorylation and chromatin tethering prevent cGAS activation during mitosis. Science 371, eabc5386 (2021).

  37. Tarn, W. Y., Cheng, Y., Ko, S. H. & Huang, L. M. Antisense oligonucleotide-based therapy of viral infections. Pharmaceutics 13, 2015 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Ahn, J. H., Jang, W. J. & Hayward, G. S. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol. 73, 10458–10471 (1999).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Chiou, C. J., Zong, J., Waheed, I. & Hayward, G. S. Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus. J. Virol. 67, 6201–6214 (1993).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Lang, D. & Stamminger, T. The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. J. Virol. 67, 323–331 (1993).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Ball, C. B. et al. Human cytomegalovirus IE2 both activates and represses initiation and modulates elongation in a context-dependent manner. mBio 13, e0033722 (2022).

    Article  PubMed  Google Scholar 

  42. Scherer, M. et al. Dual signaling via interferon and DNA damage response elicits entrapment by giant PML nuclear bodies. eLife 11, e73006 (2022).

  43. Markaki, Y. et al. Xist nucleates local protein gradients to propagate silencing across the X chromosome. Cell 184, 6174–6192.e32 (2021).

  44. Reeves, M. B., Davies, A. A., McSharry, B. P., Wilkinson, G. W. & Sinclair, J. H. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 316, 1345–1348 (2007).

    Article  PubMed  CAS  Google Scholar 

  45. Zhang, L., Xu, J., Li, M. & Chen, X. The role of long noncoding RNAs in liquid–liquid phase separation. Cell Signal 111, 110848 (2023).

    Article  PubMed  CAS  Google Scholar 

  46. Loda, A. & Heard, E. Xist RNA in action: past, present, and future. PLoS Genet. 15, e1008333 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  47. Yamazaki, T. et al. Functional domains of NEAT1 architectural lncRNA induce paraspeckle assembly through phase separation. Mol. Cell 70, 1038–1053 (2018).

    Article  PubMed  CAS  Google Scholar 

  48. West, J. A. et al. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol. Cell 55, 791–802 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Song, Z. X., Lin, J. M., Li, Z. G. & Huang, C. The nuclear functions of long noncoding RNAs come into focus. Noncoding RNA Res. 6, 70–79 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Rossetto, C. C. & Pari, G. KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome. PLoS Pathog. 8, e1002680 (2012).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Catez, F. et al. HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons. PLoS Pathog. 8, e1002852 (2012).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  52. Gentili, M. et al. The N-terminal domain of cGAS determines preferential association with centromeric DNA and innate immune activation in the nucleus. Cell Rep. 26, 2377–2393.e13 (2019).

  53. Zhong, L. et al. Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis. Cell Discov. 6, 26 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  54. Pathare, G. R. et al. Structural mechanism of cGAS inhibition by the nucleosome. Nature 587, 668–672 (2020).

    Article  PubMed  CAS  Google Scholar 

  55. Banerjee, D. et al. A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signaling. Nat. Commun. 12, 6207 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  56. Lahaye, X. et al. NONO detects the nuclear HIV capsid to promote cGAS-mediated innate immune activation. Cell 175, 488–501 (2018).

    Article  PubMed  CAS  Google Scholar 

  57. Liu, H. et al. Nuclear cGAS suppresses DNA repair and promotes tumorigenesis. Nature 563, 131–136 (2018).

    Article  PubMed  CAS  Google Scholar 

  58. Wu, Y. et al. Nuclear soluble cGAS senses double-stranded DNA virus infection. Commun. Biol. 5, 433 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  59. Mendelson, M., Monard, S., Sissons, P. & Sinclair, J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 77, 3099–3102 (1996).

    Article  PubMed  CAS  Google Scholar 

  60. Vonlaer, D. et al. Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow. Blood 86, 4086–4090 (1995).

    Article  CAS  Google Scholar 

  61. Cohen, J. I. Herpesvirus latency. J. Clin. Invest. 130, 3361–3369 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  62. Rossetto, C. C., Tarrant-Elorza, M. & Pari, G. S. Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14+ monocytes and CD34+ cells. PLoS Pathog. 9, e1003366 (2013).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  64. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589–595 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  65. Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  66. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).

    Article  PubMed  CAS  Google Scholar 

  67. Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  68. Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760–1774 (2012).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  69. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  71. Fang, Z., Liu, X. & Peltz, G. GSEApy: a comprehensive package for performing gene set enrichment analysis in Python. Bioinformatics 39, btac757 (2023).

    Article  PubMed  CAS  Google Scholar 

  72. Kim, S. et al. Temporal landscape of microRNA-mediated host–virus crosstalk during productive human cytomegalovirus infection. Cell Host Microbe 17, 838–851 (2015).

    Article  PubMed  CAS  Google Scholar 

  73. Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res. 27, 491–499 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  74. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).

    Article  PubMed  CAS  Google Scholar 

  75. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  76. Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Dunn, O. J. Multiple comparisons among means. J. Am. Stat. Assoc. 56, 52–64 (1961).

    Article  Google Scholar 

Download references

Acknowledgements

We thank all laboratory members for their productive discussions. We also thank T. Shenk for providing HCMV Toledo-BAC (AC146905.1). This work was supported by Institute for Basic Science IBS-R008-D1 (to K.A.), National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) RS-2020-NR049538 (to K.A.) and NRF-2020R1A2C3011298 to (to K.A.). This work was partially supported by funds from the SNU Institute for Virus Research.

Author information

Authors and Affiliations

Authors

Contributions

S.L. and K.A. contributed to the conceptualization and design of overall experiments. S.L. conducted virus infection and cell biological experiments. Sungchul Kim provided support for the construction of the CLIP library and SMI library. Hyejun Kim and V.N.K. contributed to bioinformatics analysis of CLIP-seq. D.L. and Sun Kim conducted mRNA sequencing analysis. J.P. contributed the microscopic image analyses. D.J., Hyewon Kim and K.P. performed biochemical experiments and cell line generation. J.H. provided support for the experiments using primary HUVEC cells. S.L., K.P., J.P. and K.A. wrote the paper.

Corresponding author

Correspondence to Kwangseog Ahn.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Microbiology thanks Alfredo Castello, Ian Mohr, Søren Paludan and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 The 1.9–4.9-kb region of RNA4.9 plays a critical role in suppressing innate immune response.

(a) Graphical abstract describing each recombinant virus. HFFs infected with WT and 1.9–4.9krpsL HCMV (1 MOI, 6 hpi) were analyzed by reverse transcription-qPCR (RT-qPCR) (n = 2). The data represents mean. “n” indicates the number of independent experiments. (b) Top-10 significant GO terms of upregulated DEGs in 1.9–4.9krpsL HCMV infected cells at the indicated time points. The GO term ranking is determined by –log10 (adj.p-value). Adjusted p-values were based on one-sided Fisher’s exact test corrected by Benjamini-Hochberg procedure. Exact adjusted p-values are provided in Supplementray Table 3. (c) IFN-β protein levels in cell-free supernatant of HCMV-infected HFFs (1 MOI) were quantified by enzyme-linked immunosorbent assay (ELISA) at the indicated time points (n = 4). (d) Graphical abstract describing each recombinant virus. (d-e) HFFs infected with WT, 1.9–4.9krpsL, and Δ1.9–4.9k HCMV (1 MOI, 6 hpi) were analyzed by RT-qPCR (n = 3). (c-e) “n” indicates the number of independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 1.

Source data

Extended Data Fig. 2 RNA4.9 inhibits innate immunity in multiple HCMV-permissive cell types.

(a-c) U373MG, MRC-5, and HUVEC cells were infected with the WT and the 1.9–4.9krpsL viruses (U373MG and MRC-5; 1 MOI, HUVEC cells; 5 MOI). Viral gDNA levels were measured by qPCR at 3 hpi and RNA expressions of interferon and cytokines were measured by RT-qPCR at the indicated time points (n = 4; a, n = 3; b-c). “n” indicates the number of independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 2.

Source data

Extended Data Fig. 3 RNA4.9 depletion-mediated immune activation precedes inefficient viral DNA replication and viral gene expression.

(a-d) HFFs infected with WT and 1.9–4.9krpsL HCMV were harvested at the indicated time points and analyzed for viral DNA level (a), viral protein expression (b), viral mRNA level (c), and immune gene expression (d). IE1, UL44, and UL99 represent viral immediate-early, early, and late transcripts, respectively. (b) The representative images of two independent replicates are presented. See Source Data for uncropped data. (a, c-d) Data are derived from four independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 3.

Source data

Extended Data Fig. 4 RNA4.9 inhibits cGAS activity to facilitate HCMV lytic replication.

(a and b) HFFs were infected with WT and 1.9–4.9krpsL HCMV (1 MOI) and were fixed at 6 hpi. (a) Phosphorylated STING (S366) and TBK1 (S172) were visualized by immunofluorescence assay (IFA). (b) Phosphorylated IRF3 (S386) and IE1/2 were visualized by IFA. White dotted lines indicate the boundary of nucleus of infected cells. Mean of raw intensity of nuclear p-IRF3 (S386) was quantified by ImageJ software (Fiji) (n = 36; Mock, n = 38; WT, n = 51; 1.9–4.9krpsL). Each “n” indicates the number of cells those were used in this analysis, which is derived from three independent experiments. The dotted lines in the violin plots indicate the median values. (c-d) 2’3’-cGAMP levels in MRC-5 and HUVEC cells infected with the indicated virus (1 MOI; MRC-5, 5 MOI; HUVEC) were measured by ELISA (n = 3). “n” indicates the number of independent experiments. (b-d) The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 4. (e) Images representing viral titers at 11 dpi in Fig. 2d. The representative images of three independent experiments are presented.

Source data

Extended Data Fig. 5 RNA4.9 inhibits dsDNA-triggered immune response independently of other viral factors.

(a) Graphical abstract describing each recombinant virus. (b) HFFs infected with the indicated HCMV (1 MOI) were harvested at 3 and 6 hpi, and subjected to RT-qPCR to measure the interferon and cytokine expressions (n = 3). (c) HeLa cells were transfected with pDEST12.2-RNA4.9 and stimulated by 0.5 μg/ml of Poly (dA:dT) or Poly (I:C). After 24 h, the cells were harvested and subjected to RT-qPCR to measure the interferon RNA level (n = 3). (d) HeLa cells were transfected with pDEST12.2-RNA4.9 and stimulated by 0.5 μg/ml of Poly (dA:dT) or 5 μg/ml of 2’3’-cGAMP. After 24 h, the cells were harvested and subjected to RT-qPCR to measure the interferon and cytokine expressions (n = 3). (b-d) “n” indicates the number of independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 5.

Source data

Extended Data Fig. 6 RNA4.9-mediated cGAS inhibition occurs in the nucleus.

(a) RNA levels in the nuclear and cytoplasmic fractions of WT HCMV-infected HFFs (1 MOI, 6 hpi) were quantified by RT-qPCR (n = 3). NEAT1 and GAPDH served as controls for nuclear RNA and cytoplasmic RNA, respectively. (b and c) HFFs were infected with WT and 1.9–4.9krpsL HCMV (1 MOI) and subjected to nucleus/cytoplasm fractionation. (b) At 6 hpi, the level of viral DNA was analyzed by qPCR using IE1 and UL44 targeting primers (n = 3). MDM2 served as controls for host DNA. (c) At 6 hpi, the cGAS level was analyzed by immunoblotting. GAPDH and Histone H3 served as controls for cytoplasmic protein and nuclear protein, respectively. The representative images of two independent experiments are presented. See Source Data for uncropped data. (d) HFFs were infected with WT and 1.9–4.9krpsL HCMV (1 MOI). At 6 and 24 hpi, the 23´-cGAMP level in nuclear fraction was analyzed by ELISA (n = 5). (a, b, and d) “n” indicates the number of independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 6.

Source data

Extended Data Fig. 7 Library construction for CLIP-seq.

(a) Immunoblot images representing the IP efficiency of the endogenous cGAS in Fig. 3a (E9G9G; Cell Signaling). (b) Immunoblot images representing the IP efficiency of the cGAS variants in Fig. 3c (F3165; Sigma). (a-b) The representative images of two independent experiments are presented. (c-e) Images were obtained during CLIP-seq library construction. (c) Immunoblot images representing the IP efficiency of cGAS antibodies (D1D3G and E9G9G; Cell signaling). (d) Autoradiograph images of 32P-labeled RNA-cGAS complexes and adaptor-ligated RNAs enriched by cGAS-CLIP. PCR amplicons of CLIP-libraries were visualized by staining with EtBR. (e) Autoradiograph images of 32P-labeled fragmented RNAs from non-crosslinked cells and adaptor-ligated RNAs. PCR amplicons of SMI-libraries were visualized by staining with EtBR. (a-e) See Source Data for uncropped data. (c-e) Two independent experiments are indicated as rep #1 and #2.

Source data

Extended Data Fig. 8 The 75-nt of cGAS-binding region of RNA4.9 is critical for accelerating HCMV lytic replication.

(a) Graphical summary of ΔRNA4.9Hairpins virus generation. RNA levels in HFFs infected with the indicated HCMV (1 MOI, 6 hpi) were analyzed by RT-qPCR (n = 3). “n” indicates the number of independent experiments. The data are presented as mean ± SEM. Exact data values are provided in Source Data Extended Data Fig 8. (b) Images representing viral titers at 7 dpi in Fig. 4d. (c) Coverage of CLIP-reads and SMI-reads mapped to the 1.9–4.9-kb region of RNA4.9. Two non-cGAS-binding regions (gray box) and a predominant cGAS-binding region (red box) were selected as ASO targets. (d) Images representing viral titers at 7 dpi in Fig. 4h. (b and d) The representative images of three independent experiments are presented.

Source data

Extended Data Fig. 9 RNA4.9-cGAS interaction is uniquely involved in cGAS inhibition.

(a) Coverage of CLIP-reads and SMI-reads mapped to HCMV transcripts. Predominant cGAS-binding regions of the HCMV transcripts (red box) were selected as ASO targets. (b) HFFs were transfected with the ASOs (250 nM) and infected with WT HCMV (1 MOI). At 24 hpi, 2´3´-cGAMP levels were measured by ELISA (n = 3). N.I indicates non-infection. “n” indicates the number of independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig 9.

Source data

Extended Data Fig. 10 Characterization of RNA4.9 localization of the mutant viruses.

(a) Linescan profile from the normalized intensity of HCMV DNA and IE1/2 foci signals (related to Fig. 5a; n = 11). Signal distributions of HCMV DNAs are identical with those in Fig. 5b. “n” indicates the number of nuclear HCMV DNA or IE1/2 signals which were observed in the cells from three independent experiments. The cell numbers are identical with Extended Data Fig. 10b. The bold line and the shaded region indicate mean and 95% confidence interval (CI), respectively (b) The ratio of IE1/2 or RNA4.9 signals associated with EdU signals to total EdU signals in the nucleus was quantified (related to Fig. 5a). For each channel, the signals with an intensity in the upper 0.05 to 0.1% in the nucleus participated in quantification to exclude background noise signal. Each dot represents the individual cell (n = 6). “n” indicates the number of cells those were used in this analysis, which was obtained from three independent experiments. (c and f) Graphical abstract describing each recombinant virus. RNA levels in HFFs infected with the indicated HCMV (1 MOI, 6 hpi) were analyzed by RT-qPCR (n = 3). (d and g) Viral gDNA levels in HFFs infected with the indicated HCMV (1 MOI, 3 hpi) were analyzed by qPCR (n = 3). (e) Viral productions from the HFFs infected with the indicated HCMV (0.1 MOI) were titrated by limiting dilution analysis (n = 3). (c-g) “n” indicates the number of independent experiments. (b-g) The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig 10.

Source data

Supplementary information

Supplementary Information (download PDF )

Supplementary Figs. 1–8 and Source Data for Supplementary Fig. 7.

Reporting Summary (download PDF )

Peer Review File (download PDF )

Supplementary Data (download XLSX )

Statistical source data for Supplementary Figs. 1–3 and 5–6.

Supplementary Table 1 (download XLSX )

Primers for BAC mutagenesis.

Supplementary Table 2 (download XLSX )

Primers for qPCR.

Supplementary Table 3 (download XLSX )

mRNA sequencing data.

Supplementary Table 4 (download XLSX )

Modified ASOs.

Supplementary Table 5 (download XLSX )

smFISH probes.

Supplementary Table 6 (download XLSX )

PCR primers for construction of CLIP and SMI libraries.

Supplementary Table 7 (download XLSX )

TPM for the HCMV transcripts from CLIP-seq.

Source data

Source Data Fig. 1 (download XLSX )

Statistical source data for Fig. 1.

Source Data Fig. 2 (download XLSX )

Statistical source data for Fig. 2.

Source Data Fig. 3 (download XLSX )

Statistical source data for Fig. 3.

Source Data Fig. 4 (download XLSX )

Statistical source data for Fig. 4.

Source Data Fig. 5 (download XLSX )

Statistical source data for Fig. 5.

Source Data Fig. 6 (download XLSX )

Statistical source data for Fig. 6.

Source Data Extended Data Fig. 1 (download XLSX )

Statistical source data for Extended Data Fig. 1.

Source Data Extended Data Fig. 2 (download XLSX )

Statistical source data for Extended Data Fig. 2.

Source Data Extended Data Fig. 3 (download XLSX )

Statistical source data for Extended Data Fig. 3.

Source Data Extended Data Fig. 4 (download XLSX )

Statistical source data for Extended Data Fig. 4.

Source Data Extended Data Fig. 5 (download XLSX )

Statistical source data for Extended Data Fig. 5.

Source Data Extended Data Fig. 6 (download XLSX )

Statistical source data for Extended Data Fig. 6.

Source Data Extended Data Fig. 8 (download XLSX )

Statistical source data for Extended Data Fig. 8.

Source Data Extended Data Fig. 9 (download XLSX )

Statistical source data for Extended Data Fig. 9.

Source Data Extended Data Fig. 10 (download XLSX )

Statistical source data for Extended Data Fig. 10.

Source Data Figs. 1 and 2, and Extended Data Figs. 3, 6 and 7 (download PDF )

Uncropped immune blots and gels of Figs. 1 and 2, and Extended Data Figs. 3, 6 and 7.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, S., Kim, S., Kim, H. et al. Human cytomegalovirus long non-coding RNA counteracts nuclear cGAS to facilitate immune evasion. Nat Microbiol 10, 2275–2290 (2025). https://doi.org/10.1038/s41564-025-02078-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41564-025-02078-5

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing